| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 01/14/1998 | EP0817772A1 Pyrrolidinyl hydroxamic acid compounds and their production process |
| 01/14/1998 | EP0817770A1 Nonpeptides as tachykinin antagonists |
| 01/14/1998 | EP0817646A2 Methods of treating inflammation and compositions therefor |
| 01/14/1998 | EP0817636A1 Cinnamoyl-c-glycoside chromone isolated from aloe barbadensis |
| 01/14/1998 | EP0817635A1 Use of thiazepine, oxazepine and diazepine coumpounds for inhibiting hiv, herpesvirus and suppressing the immune system |
| 01/14/1998 | EP0817634A1 Azathioprine compositions for colonic administration |
| 01/14/1998 | EP0817631A2 Low dose ridogrel formulations and their use for the treatment of inflammatory bowel diseases |
| 01/14/1998 | EP0817628A2 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
| 01/14/1998 | EP0817627A1 Protein kinase c inhibitors |
| 01/14/1998 | EP0708648A4 Inhibition of tumor necrosis factor and nitric oxide production by retinoic acid |
| 01/14/1998 | EP0651738B1 Natural amino acid derivatives as metalloproteinase inhibitors |
| 01/14/1998 | EP0642336B1 Use of nsiad in the treatment of dementia |
| 01/14/1998 | CN1170412A Suger modified nucleosides and their use for synthesis of oligonucleotides |
| 01/14/1998 | CN1170366A Combined use of diclofenac and tribenoside to treat osteoarthritis |
| 01/13/1998 | US5708033 Antiinflammatory agents, antiarthritic agents or analgesics |
| 01/13/1998 | US5708024 Salts of 2- (2,6-dichlorophenyl)amine!phenylacetoxyacetic acid with organic basic cations |
| 01/13/1998 | US5708016 Pseudopeptides derived from neurokinins |
| 01/13/1998 | US5708010 Methods of inhibiting myeloperoxidase activity |
| 01/13/1998 | US5708009 Methods of inhibiting myeloperoxidase activity |
| 01/13/1998 | US5707989 Pyrimido 5,4-D!pyrimidines, medicaments comprising these compounds, their use and processes for their preparation |
| 01/13/1998 | US5707984 Smooth muscle relaxants |
| 01/13/1998 | US5707978 Antitumor agents, psoriasis, antiinflammatory agents |
| 01/13/1998 | US5707829 DNA sequences and secreted proteins encoded thereby |
| 01/13/1998 | US5707815 Polypeptides produced bby expression of heterologous nucleic acid in cells and encoded by dna and hybridize |
| 01/13/1998 | US5707635 Containing a crosslinked polyacrylamide-type polymer and an active compound, optionally a humectant and an emollient |
| 01/13/1998 | US5707622 Methods for treating ulcerative colitis |
| 01/12/1998 | CA2210056A1 Cyclic sulfone derivatives |
| 01/10/1998 | CA2208676A1 Mercaptoketones and mercaptoalcohols and a process for their preparation |
| 01/08/1998 | WO1998000145A1 Topical administration of certain azaspiranes to prevent or treat skin conditions associated with hyperproliferation of skin cells and/or immunologically mediated disorders |
| 01/08/1998 | WO1997041824A3 Antiangiogenic peptides derived from plasminogen |
| 01/08/1998 | DE19728279A1 Ketoprofen plaster with long-term and immediate effect, |
| 01/07/1998 | EP0816502A2 Mur A-1, an UDP-N-acetylglucosamine enolpyruvyl-transferase from Streptococcus pneumoniae |
| 01/07/1998 | EP0816497A2 Human requiem polypeptide for apoptosis |
| 01/07/1998 | EP0816357A1 Substituted indazole derivatives |
| 01/07/1998 | EP0815228A2 Cellubrevin homologs |
| 01/07/1998 | EP0815223A1 Dermatomyositis-specific auto-antigen |
| 01/07/1998 | EP0815202A1 Human tissue inhibitor of metalloproteinase-4 |
| 01/07/1998 | EP0815142A1 Antigen composition against mycoplasma |
| 01/07/1998 | EP0815127A1 Fucopeptides |
| 01/07/1998 | EP0815126A1 Bicyclic tachykinins antagonists, preparation thereof and their use in pharmaceutical composition |
| 01/07/1998 | EP0815107A1 Morpholine derivatives, compositions containing them and their use as therapeutic agents |
| 01/07/1998 | EP0815088A1 Aromatic compounds useful as tachykinin antagonists |
| 01/07/1998 | EP0815087A1 Trisubstituted phenyl derivatives |
| 01/07/1998 | EP0815084A1 Lactam-containing hydroxamic acid derivatives, their preparation and their use as inhibitors of matrix metalloprotease |
| 01/07/1998 | EP0814842A1 Method for treating amyloidosis |
| 01/07/1998 | EP0814837A1 Use of g class immunoglobulins for the topical treatment of atopic dermatitis |
| 01/07/1998 | EP0814832A1 ISOFORMS OF HUMAN INTERLEUKIN-1$g(b) CONVERTING ENZYME AND METHODS OF USING THE SAME |
| 01/07/1998 | EP0814815A1 Poly(hydroxy acid)/polymer conjugates for skin applications |
| 01/07/1998 | EP0814813A2 Use of penciclovir for the treatment of human herpes-virus-8 |
| 01/07/1998 | EP0814809A1 Aryl thioxanthines |
| 01/07/1998 | EP0814808A1 Pharmaceutical, cosmetic and/or food composition having anti-oxidant properties |
| 01/07/1998 | EP0814792A1 Mercapto and seleno derivatives as inhibitors of nitric oxide synthase |
| 01/07/1998 | EP0814776A1 Topically applied pharmaceutical composition, method of preparing it and its use |
| 01/07/1998 | EP0814774A1 Reduction of adhesions using controlled delivery of active oxygen inhibitors |
| 01/07/1998 | EP0700301A4 Peptides and compounds that bind to elam-1 |
| 01/07/1998 | EP0613458B1 Acyclic ethylenediamine derivatives as substance p receptor antagonists |
| 01/07/1998 | EP0552142B1 T cell receptor peptides as therapeutics for autoimmune and malignant disease |
| 01/07/1998 | EP0464175B1 Extracellular form of the human fibroblast growth factor receptor |
| 01/07/1998 | CN1169722A 5-lipoxygenase inhibitors |
| 01/07/1998 | CN1169426A Novel pyridajinone derivatives |
| 01/07/1998 | CN1036920C Heterocycle-containing carbonic acid derivatives |
| 01/06/1998 | US5705615 Antibodies specific for HTm4 |
| 01/06/1998 | US5705525 Thiophene compounds |
| 01/06/1998 | US5705522 Compounds having anti-inflammatory and anti-viral activity, compositions of these, alone and in combination with reverse transcriptase inhibitors |
| 01/06/1998 | US5705520 Medicaments |
| 01/06/1998 | US5705511 Fused pyrrolocarbazoles |
| 01/06/1998 | US5705360 Chemokine N-terminal deletion mutations |
| 01/06/1998 | US5705158 Kits with antileukocyte antibody conjugates |
| 12/31/1997 | WO1997049827A2 Adenoviral mediated gene transfer in adipocytes and related implants |
| 12/31/1997 | WO1997049818A2 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 12/31/1997 | WO1997049710A1 Spiro-piperidine derivatives and their use as therapeutic agents |
| 12/31/1997 | WO1997049702A1 Substituted indazole derivatives and their use as phosphodiesterase (pde) type iv and tumor necrosis factor (tnf) inhibitors |
| 12/31/1997 | WO1997049680A1 Il-8 receptor antagonists |
| 12/31/1997 | WO1997049406A1 Use of k-252a derivative for the treatment of peripheral or central nerve disorders, and cytokine overproduction |
| 12/31/1997 | WO1997049405A1 Topical gel composition containing a combination of a nsaid and a xanthine derivative |
| 12/31/1997 | CN1168793A Injection adhesion and method for preparing same |
| 12/31/1997 | CA2259228A1 Adenoviral mediated gene transfer in adipocytes and related implants |
| 12/31/1997 | CA2258850A1 Il-8 receptor antagonists |
| 12/31/1997 | CA2258199A1 Topical gel composition containing a combination of a nsaid and a xanthine derivative |
| 12/31/1997 | CA2257964A1 Spiro-piperidine derivatives and their use as therapeutic agents |
| 12/31/1997 | CA2231732A1 Sustained release sufentanil compositions |
| 12/30/1997 | US5703240 Analgesics; antiinflammatory agents; nervous system disorders; psychological disorders; gastrointestinal disorders |
| 12/30/1997 | US5703100 Modulators of acetylcholine receptors |
| 12/30/1997 | US5703098 Inhibitors of cytokines including tumor necrosis factor |
| 12/30/1997 | US5703095 Prevention ferritin from releasing oxygen |
| 12/30/1997 | US5703092 Hydroxamic acid compounds as metalloprotease and TNF inhibitors |
| 12/30/1997 | US5703082 Enantiomers of 1- (4-chlorophenyl)phenylmethyl!- (4-methylphenyl)sulfonyl!pi |
| 12/30/1997 | US5703077 Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives |
| 12/30/1997 | US5703073 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs |
| 12/30/1997 | US5703069 Method for inhibiting and controlling viral growth |
| 12/30/1997 | US5703065 Heteroarylamino and heteroarylsulfonamido substituted 3-benyzlaminomethyl piperidines and related compounds |
| 12/30/1997 | US5703054 Oligonucleotide modulation of protein kinase C |
| 12/30/1997 | US5703038 Emhanced biological activity |
| 12/30/1997 | US5702946 Interleukins |
| 12/30/1997 | US5702920 Polypeptides |
| 12/30/1997 | US5702724 Compressing inclusion compound containing diclofenac or salt and cyclodextrin into tablets |
| 12/30/1997 | US5702720 Involving an acrylate or mathacrylate based copolymer, a skin penetration enhancer, a polyvinylpyrrolidone polymer and flurbiprofen drug; antiinflamatory, analgesic and antipyretic agent |
| 12/30/1997 | US5702698 Promoting production of colony stimulating factor |
| 12/30/1997 | CA2067863C Medicine for the treatment of illnesses of the respiratory organs |
| 12/29/1997 | EP0814158A2 Human C3a receptor variant; uses in diagnostics and therapeutics |